Species: Lactobacillus gasseri (HMT-0615) Primary Body Site: Vaginal
Download Options
LINKS: Ecology Home
| HMT-0615: [Body Sites Data]
[Taxon Description]
| Life Page: Lactobacillus gasseri
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.02 | 0.01 | 0 | 0.01 | 0.69 | 0.77 | 1.67 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.01 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.01 | 0.02 | 0 | 0.01 | 1.82 | 1.86 | 2.12 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.11 | 0.02 | 0 | 0 | 1.24 | 1.75 | 6.08 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.00 | 25.00 | 21.28 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.09 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.05 | 0.03 | 0.01 | 0.60 | 0.07 | 9.26 | 9.76 | 10.39 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.24 | 46.17 | 47.40 | 0 |
| Stdev | 1.08 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0.59 | 0.34 | 0.08 | 7.33 | 0.42 | 22.37 | 25.11 | 26.24 | 0 |
| Prev(%) | 7.95 | 0 | 0 | 0 | 6.04 | 0 | 0 | 0 | 0 | 9.67 | 7.18 | 5.95 | 8.05 | 7.37 | 50.70 | 45.95 | 44.74 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Neither HMT-615 nor HMT-819 were present singularly so these reads were split evenly at these sites (MVA,PFO,PTO,SUBP,VIN).
Neither HMT-615 nor HMT-819 were present singularly so these reads were split evenly at these sites (MVA,PFO,PTO,SUBP,VIN).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 3.67 | 3.50 | 3.58 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.79 | 4.50 | 7.27 | 0 |
| Stdev | 0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 10.49 | 10.89 | 11.36 | 0 |
| Prev(%) | 4.20 | 0 | 0 | 0 | 0 | 0 | 0 | 4.38 | 0 | 0 | 0 | 0 | 0 | 0 | 69.54 | 47.54 | 45.03 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.04 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.07 | 0 | 0 | 0 |
| Prev(%) | 8.11 | 8.82 | 2.33 | 17.14 | 7.14 | 4.00 | 3.03 | 3.23 | 0 | 10.00 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.40 | 0.34 | 5.40 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.56 | 0.33 | 7.08 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 2.75 | 1.11 | 19.00 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 0 | 0 | 12.50 | 0 | 0 | 0 | 1.35 | 0 | 0 | 0 | 36.36 | 28.57 | 26.77 | 0 |

